Theorem Clinical Research Inc. Leaders Will Attend AdvaMED MedTech Conference

Theorem Clinical Research Inc. Leaders Will Attend AdvaMED MedTech Conference

<0> Theorem Clinical ResearchShawn Clary, 484.679.2400 </0>

experts , M.D., J.D., F.C.L.M., Vice President of Medical and Scientific Affairs, Medical Device and Diagnostics, and Suzan Olson, Ph.D., M.H.S., RN, Associate Director, Medical Devices, will attend the 2012 scheduled for October 1-3 at the Boston Convention and Exhibition Center. Both are widely published and highly sought-after experts who have 45 years of combined clinical trial experience.

Dr. Rosenfeld’s specialty training as a physician is in the area of physical medicine and rehabilitation, with a focus on neurorehabilitation. He has more than 25 years of experience in clinical research and strategic regulatory consulting for medical devices relating to hematology, gastroenterology, oncology, neurology, neurorehabilitation and pain. His therapeutic expertise likewise involves medical devices in all these areas, with extensive professional activities involving both external and implantable functional electrical stimulation and neuromodulation devices intended to treat patients with various central and peripheral neurological diseases and injuries, as well as products intended to treat musculoskeletal and orthopedic conditions.

Dr. Olson is a human factors psychologist and has a certificate in Master Black Belt Lean Six Sigma certification. Her areas of therapeutic expertise for medical devices include orthopedics, urology, pain pumps, implantable cardiovascular devices, peripheral access devices, light therapy and lifting gurneys used with helicopters and fixed-wing air ambulances. She has 13 years' experience in clinical trials administration and more than 20 years of experience in health care service.

With regard to the upcoming meeting in Boston, Dr. Rosenfeld stated, “My colleagues and I at Theorem Clinical Research look forward to the upcoming AdvaMed conference to foster our current working associations with attendees from the health care technology industry. We will also establish new relationships with other medical product sponsors who seek assistance with their clinical study endeavors and their various related regulatory strategies and activities.”

is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's leading pharmaceutical, biotech and medical device companies. A world leader in the most complex medical device and drug-device combination trials in addition to a notable capability in pharmaceuticals and biologics, Theorem has deep expertise in a broad range of therapeutic areas and in all phases of development. Some of the industry's top scientists and most advanced clinical analytics capabilities help ensure smooth-running, successful trials. For a full-service, right-size global research partner, don't think twice. .

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.